Uncategorized
ProtoKinetix Enters into 3rd Phase of Retinal Cell Replacement Therapy Testing at UBC
MARIETTA, Ohio--(BUSINESS WIRE)--ProtoKinetix Enters into 3rd Phase of Retinal Cell Replacement Therapy Testing at the University of British Columbia